Donald Healey
Technik-/Wissenschafts-/F&E-Leiter bei ADICET BIO, INC.
Vermögen: 63 764 $ am 30.04.2024
Aktive Positionen von Donald Healey
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ADICET BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 26.10.2020 | - |
Karriereverlauf von Donald Healey
Ehemalige bekannte Positionen von Donald Healey
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC. | Geschäftsführer | 01.02.2017 | 01.10.2020 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Technik-/Wissenschafts-/F&E-Leiter | 02.08.2013 | 01.02.2017 |
Corporate Officer/Principal | 24.09.2010 | 02.08.2013 | |
British Society for Immunology
British Society for Immunology Miscellaneous Commercial ServicesCommercial Services The British Society for Immunology provides membership organization services. The non-profit company is based in London, UK. | Corporate Officer/Principal | 01.01.1998 | 01.01.1998 |
ARGOS THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Ausbildung von Donald Healey
University of Bristol | Undergraduate Degree |
University of London | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Vereinigtes Königreich | 4 |
Operativ
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ADICET BIO, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
Argos Therapeutics, Inc.
Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
British Society for Immunology
British Society for Immunology Miscellaneous Commercial ServicesCommercial Services The British Society for Immunology provides membership organization services. The non-profit company is based in London, UK. | Commercial Services |
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC. | Commercial Services |
- Börse
- Insiders
- Donald Healey
- Erfahrung